Massachusetts Financial Services CO Recursion Pharmaceuticals, Inc. Transaction History

Massachusetts Financial Services CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$7.83 - $13.6 $2.95 Million - $5.12 Million	-376,499 Reduced 28.37%	950,594 $10.1 Million
Q2 2022 Aug 09, 2022	SELL	$5.04 - $9.26 $48,671 - $89,423	-9,657 Reduced 0.72%	1,327,093 $10.8 Million
Q1 2022 May 11, 2022	BUY	$6.16 - $18.03 $226,127 - $661,863	36,709 Added 2.82%	1,336,750 $9.57 Million
Q4 2021 Feb 10, 2022	BUY	$16.14 - $21.86 $6.52 Million - $8.84 Million	404,181 Added 45.12%	1,300,041 $22.3 Million
Q3 2021 Nov 10, 2021	SELL	$19.03 - $41.33 $1.52 Million - $3.31 Million	-80,069 Reduced 8.2%	895,860 $20.6 Million
Q2 2021 Aug 13, 2021	BUY	$18.0 - $37.42 $17.6 Million - $36.5 Million	975,929 New	975,929 $35.6 Million

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.38B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.